NXP Semiconductors NV (Nasdaq:NXPI) announced that its CGV™ series of JESD204A-compliant data converters are now interoperable with Nujira's OpenET envelope tracking (ET) and digital pre-distortion (DPD) solutions. Nujira is a leader in commercial-grade envelope tracking modulators for 3G and 4G wireless infrastructure applications, and is the founder of the OpenET Alliance. NXP CGV analog-to-digital converters (ADCs) and digital-to-analog converters (DACs) are the first in the industry to implement the JEDEC JESD204A serial interface, which dramatically reduces the number of interconnect signals between data converters and VLSI logic devices, and enables synchronous bonding of multiple data converter channels or lanes. Nujira's next-generation Coolteq-h Envelope Tracking modulators now also support JESD204A as an interface option.
NXP Semiconductors N.V., through its subsidiary NXP B.V., provides mixed signal solutions and semiconductor components.
Power3 Medical Products, Inc. (OTC.BB:PWRM) a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
Alzheimer's disease isn't an ordinary part of getting older, even though greatest known risk factor is increasing age. The largest part of people today with Alzheimer's tend to be 65 and older. But Alzheimer's is not just a sickness of old age. Up to 5% of people with the sickness currently have early-onset Alzheimer's (also referred to as younger-onset), which frequently appears when someone is in his or her 40s or 50s.
Soon after cancer of the skin, cancers of the breast is a very common cancer recognized in females. However breast cancer rates have decreased in recent times, even if physicians are not certain why. Nevertheless, for numerous women, breast cancer could be the condition they fear most.
Parkinson's disease (PD) is part of a team of ailments known as motor system disorders, which are the result of the loss of dopamine-producing brain cells. The 4 fundamental symptoms of PD are tremor, or moving in hands, arms, legs, jaw, and face; hardness, or perhaps tightness of your limbs and trunk; bradykinesia, or slowness to move; and postural lack of stability, or inable sense of balance and also co-ordination. As far as signs and symptoms, they are more noticable, patients might have trouble walking, talking, or finishing many other very simple tasks.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
GreenHouse Holdings, Inc. (OTCQB:GRHU), a leading provider of energy efficiency solutions and sustainable infrastructure products, announced that it has been engaged to implement Southern California Edison's (SCE) Automated Demand Response (Auto-DR) program for three commercial/industrial customers. The customers include the PepsiCo® Carson bottling facility, Sigma Plating and CRP MB Studio, LLC.
GreenHouse estimates that the projects will generate $500,000 in revenue to the company. This projection is based upon approximately 1,500 kW or 1.5 MW of electricity demand reduction and infrastructure improvements from the engagements. GreenHouse is a qualified service provider of SCE's Auto-DR program, providing site assessment, feasibility studies, project development, engineering, and installation of enabling technologies including complete processing of all utility documents.
The Auto-DR program offers significant financial incentives and technical support to Southern California Edison (SCE) customers willing to install equipment that enables participation in demand response events versus depending on their employees to perform all the curtailment activities manually when required. Normally, control systems (automation) are installed with the programming needed to achieve reductions in electricity consumption during peak periods of demand on the grid.
GreenHouse Holdings, Inc. is a leading provider of energy efficiency solutions and sustainable infrastructure products. The company designs, engineers and installs disparate products and technologies that produce persistent technical and financial results, by enabling clients to monitor and control their energy costs in the most efficient manner possible. Its target markets for energy efficiency solutions include residential, commercial and industrial, as well as government and military markets. In addition, the company develops, designs and constructs rapidly deployable, sustainable infrastructure primarily for use in disaster relief and security in austere regions.
Stonemor Partners LP (Nasdaq:STON) announced that it has increased its cash distribution to $0.5750 per unit ($2.30 annualized), payable on February 14, 2011, to common and subordinated unit holders of record as of the close of business on January 31, 2011. StoneMor plans to hold an investors' conference call to review its fourth quarter and year-end results (which will be released before this call) on Wednesday, March 16, 2011, at 11:00 a.m. Eastern Time.
StoneMor Partners L.P., together with its subsidiaries, engages in the ownership and operation of cemeteries in the United States. The company operates in two segments, Cemetery Operations and Funeral Homes.
LKQ Corp. (Nasdaq:LKQX) the largest nationwide provider of aftermarket collision replacement parts, recycled light vehicle parts, and refurbished bumpers and wheels, will release its financial results for its fourth quarter and full year 2010 on Thursday, February 24, 2011, before the market opens. The same day, the Company will host a conference call for the investment community at 10:00 a.m. Eastern Time (9:00 a.m. Central Time) and a simultaneous audio webcast. To access the investor conference call, please dial (877) 407-0315. International access to the call may be obtained by dialing (201) 689-8501. The audio webcast can be accessed via the Company's website at www.lkqcorp.com in the Investor Relations section.
LKQ Corporation, together with its subsidiaries, provides replacement systems, components, and parts needed to repair vehicles in the United States. It provides aftermarket products, recycled products, and refurbished products.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period.
Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).
Crown Equity Holdings Inc. (OTCPK:CRWE) has received ten thousand dollars in cash and anticipates another ten thousand dollars in cash from the company for 60 days of advertisement services for Green House Holdings, Inc. (GRHU). In addition to the cash, Crown Equity Holdings Inc. (OTCPK:CRWE) also anticipates receiving 20,000 shares of 144 restricted stocks from a third party.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.